Nicholas I. Obiri

2.3k total citations
24 papers, 2.0k citations indexed

About

Nicholas I. Obiri is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Biotechnology. According to data from OpenAlex, Nicholas I. Obiri has authored 24 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 13 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Biotechnology. Recurrent topics in Nicholas I. Obiri's work include Toxin Mechanisms and Immunotoxins (17 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Transgenic Plants and Applications (9 papers). Nicholas I. Obiri is often cited by papers focused on Toxin Mechanisms and Immunotoxins (17 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Transgenic Plants and Applications (9 papers). Nicholas I. Obiri collaborates with scholars based in United States, Thailand and Japan. Nicholas I. Obiri's co-authors include Raj K. Puri, Waldemar Debinski, Takashi Murata, Ira Pastan, Warren J. Leonard, Pamela Leland, William S. Modi, Nahid Tayebi, M. Javad Aman and S K Powers and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Biotechnology.

In The Last Decade

Nicholas I. Obiri

24 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas I. Obiri United States 18 1.6k 574 447 372 358 24 2.0k
Alexander L. Rakhmilevich United States 34 1.9k 1.2× 1.4k 2.4× 247 0.6× 759 2.0× 254 0.7× 99 2.8k
Jeanette Dilley United States 24 930 0.6× 599 1.0× 193 0.4× 978 2.6× 776 2.2× 32 2.5k
Christopher A. Pennell United States 25 1.3k 0.8× 414 0.7× 141 0.3× 553 1.5× 442 1.2× 49 1.9k
Joyce C. Solheim United States 30 1.6k 1.0× 714 1.2× 83 0.2× 1.1k 2.8× 236 0.7× 94 2.7k
Susana Inogés Spain 28 1.8k 1.2× 1.2k 2.1× 189 0.4× 912 2.5× 269 0.8× 65 3.0k
Ikumi Katano Japan 18 934 0.6× 482 0.8× 118 0.3× 312 0.8× 95 0.3× 39 1.5k
Suyu Shu United States 36 3.0k 1.9× 2.0k 3.5× 194 0.4× 800 2.2× 217 0.6× 95 3.8k
Charlotte M. Fryling United States 12 386 0.2× 385 0.7× 233 0.5× 875 2.4× 197 0.6× 14 1.5k
Gerald Siu United States 28 2.3k 1.5× 634 1.1× 58 0.1× 1.2k 3.2× 766 2.1× 38 3.3k
Nancy Oppenheimer‐Marks United States 24 1.2k 0.8× 350 0.6× 74 0.2× 499 1.3× 437 1.2× 33 2.3k

Countries citing papers authored by Nicholas I. Obiri

Since Specialization
Citations

This map shows the geographic impact of Nicholas I. Obiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas I. Obiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas I. Obiri more than expected).

Fields of papers citing papers by Nicholas I. Obiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas I. Obiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas I. Obiri. The network helps show where Nicholas I. Obiri may publish in the future.

Co-authorship network of co-authors of Nicholas I. Obiri

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas I. Obiri. A scholar is included among the top collaborators of Nicholas I. Obiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas I. Obiri. Nicholas I. Obiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Obiri, Nicholas I., et al.. (2023). Implementation of the Eat, Sleep, and Console Model of Care: A Quality Improvement Project. Neonatal Network The Journal of Neonatal Nursing. 42(6). 320–328. 4 indexed citations
2.
Debinski, Waldemar, et al.. (1998). Novel anti–brain tumor cytotoxins specific for cancer cells. Nature Biotechnology. 16(5). 449–453. 99 indexed citations
3.
Murata, Takashi, Nicholas I. Obiri, & Raj K. Puri. (1998). Structure of and signal transduction through interleukin-4 and interleukin-13 receptors (review).. International Journal of Molecular Medicine. 1(3). 551–7. 120 indexed citations
4.
Murata, Takashi, Nicholas I. Obiri, Waldemar Debinski, & Raj K. Puri. (1997). Structure of IL-13 Receptor: Analysis of Subunit Composition in Cancer and Immune Cells. Biochemical and Biophysical Research Communications. 238(1). 90–94. 115 indexed citations
5.
Obiri, Nicholas I., Pamela Leland, Takashi Murata, Waldemar Debinski, & Raj K. Puri. (1997). The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. The Journal of Immunology. 158(2). 756–764. 135 indexed citations
6.
Obiri, Nicholas I., Takashi Murata, Waldemar Debinski, & Raj K. Puri. (1997). Modulation of Interleukin (IL)-13 Binding and Signaling by the γc Chain of the IL-2 Receptor. Journal of Biological Chemistry. 272(32). 20251–20258. 46 indexed citations
7.
Murata, Takashi, Nicholas I. Obiri, & Raj K. Puri. (1997). Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: Comparison between IL-4- and IL-13-induced signal transduction. International Journal of Cancer. 70(2). 230–240. 57 indexed citations
8.
Puri, Raj K., Pamela Leland, Nicholas I. Obiri, et al.. (1996). An Improved Circularly Permuted Interleukin 4-Toxin Is Highly Cytotoxic to Human Renal Cell Carcinoma Cells. Cellular Immunology. 171(1). 80–86. 37 indexed citations
9.
Leland, Pamela, et al.. (1996). Receptor for Interleukin (IL) 13 Does Not Interact with IL4 but Receptor for IL4 Interacts with IL13 on Human Glioma Cells. Journal of Biological Chemistry. 271(37). 22428–22433. 78 indexed citations
10.
Aman, M. Javad, Nahid Tayebi, Nicholas I. Obiri, et al.. (1996). cDNA Cloning and Characterization of the Human Interleukin 13 Receptor α Chain. Journal of Biological Chemistry. 271(46). 29265–29270. 252 indexed citations
11.
Debinski, Waldemar, Nicholas I. Obiri, Ira Pastan, & Raj K. Puri. (1995). A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4. Journal of Biological Chemistry. 270(28). 16775–16780. 183 indexed citations
12.
Obiri, Nicholas I., Waldemar Debinski, Warren J. Leonard, & Raj K. Puri. (1995). Receptor for Interleukin 13. Journal of Biological Chemistry. 270(15). 8797–8804. 229 indexed citations
13.
Obiri, Nicholas I., et al.. (1995). Up‐regulation of intercellular adhesion molecule 1 (ICAM‐1) on human renal cell carcinoma cells by interleukin‐4. International Journal of Cancer. 61(5). 635–642. 15 indexed citations
14.
Puri, Raj K., Waldemar Debinski, Nicholas I. Obiri, Robert J. Kreitman, & Ira Pastan. (1994). Human Renal Cell Carcinoma Cells Are Sensitive to the Cytotoxic Effect of a Chimeric Protein Composed of Human Interleukin-4 and Pseudomonas Exotoxin. Cellular Immunology. 154(2). 369–379. 17 indexed citations
15.
Obiri, Nicholas I., Jay P. Siegel, Frederick Varricchio, & Raj K. Puri. (1994). Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clinical & Experimental Immunology. 95(1). 148–155. 113 indexed citations
16.
Obiri, Nicholas I., et al.. (1993). Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.. Journal of Clinical Investigation. 91(1). 88–93. 153 indexed citations
17.
Varricchio, Frederick, Nicholas I. Obiri, Gabriel P. Haas, & Raj K. Puri. (1993). Immunostaining of interleukin-4 receptor on human renal cell carcinoma.. PubMed. 12(6). 465–9. 19 indexed citations
18.
Obiri, Nicholas I., et al.. (1990). Patterns of cytokines released by peripheral blood leukocytes of normal donors and cancer patients during interleukin-2 activation in vitro.. PubMed. 9(2). 140–8. 13 indexed citations
19.
Pruett, Stephen B., Nicholas I. Obiri, & Johnathan L. Kiel. (1989). Involvement and relative importance of at least two distinct mechanisms in the effects of 2‐mercaptoethanol on murine lymphocytes in culture. Journal of Cellular Physiology. 141(1). 40–45. 26 indexed citations
20.
Obiri, Nicholas I. & Stephen B. Pruett. (1988). The role of thiols in lymphocyte responses: Effect of 2-mercaptoethanol on interleukin 2 production. Immunobiology. 176(4-5). 440–449. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026